Cargando…

Advances in Immunotherapy for Hepatitis B

Hepatitis B virus (HBV) is a hepatotropic virus with the potential to cause chronic infection, and it is one of the common causes of liver disease worldwide. Chronic HBV infection leads to liver cirrhosis and, ultimately, hepatocellular carcinoma (HCC). The persistence of covalently closed circular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Dongyao, Fu, Binqing, Wei, Haiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612046/ https://www.ncbi.nlm.nih.gov/pubmed/36297173 http://dx.doi.org/10.3390/pathogens11101116

Ejemplares similares

Natural killer cells in tumor immunotherapy
por: Wang, Dongyao, et al.
Publicado: (2023)

Immunomodulation Induced During Interferon-α Therapy Impairs the Anti-HBV Immune Response Through CD24(+)CD38(hi) B Cells
por: Fu, Binqing, et al.
Publicado: (2020)

Hepatectomy promotes recurrence of liver cancer by enhancing IL-11-STAT3 signaling
por: Wang, Dongyao, et al.
Publicado: (2019)

IL-6 modulation for COVID-19: the right patients at the right time?
por: Ascierto, Paolo Antonio, et al.
Publicado: (2021)

KIR3DS1/HLA-B Bw4-80Ile Genotype Is Correlated with the IFN-α Therapy Response in hepatitis B e antigen-Positive Chronic Hepatitis B
por: Li, Wenting, et al.
Publicado: (2017)

NKp30(+) NK cells are associated with HBV control during pegylated-interferon-alpha-2b therapy of chronic hepatitis B
por: Shen, Xiaokun, et al.
Publicado: (2016)

Restoration of HBV-specific CD8(+) T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-α therapy
por: Wang, Dongyao, et al.
Publicado: (2021)

Why tocilizumab could be an effective treatment for severe COVID-19?
por: Fu, Binqing, et al.
Publicado: (2020)

Cytomegalovirus-specific neutralizing antibodies effectively prevent uncontrolled infection after allogeneic hematopoietic stem cell transplantation
por: Wang, Huiru, et al.
Publicado: (2022)

Single-cell transcriptomics reveal a unique memory-like NK cell subset that accumulates with ageing and correlates with disease severity in COVID-19
por: Guo, Chuang, et al.
Publicado: (2022)

CD3(bright)CD56(+) T cells associate with pegylated interferon-alpha treatment nonresponse in chronic hepatitis B patients
por: Guo, Chuang, et al.
Publicado: (2016)

CD11b(−)CD27(−) NK Cells Are Associated with the Progression of Lung Carcinoma
por: Jin, Jing, et al.
Publicado: (2013)

Hepatitis B vaccination and immunotherapies: an update
por: Stasi, Cristina, et al.
Publicado: (2020)

TGF-β1 Down-Regulation of NKG2D/DAP10 and 2B4/SAP Expression on Human NK Cells Contributes to HBV Persistence
por: Sun, Cheng, et al.
Publicado: (2012)

Immunotherapy for Chronic Hepatitis B Virus Infection
por: Bertoletti, Antonio, et al.
Publicado: (2018)

GARP-mediated active TGF-β1 induces bone marrow NK cell dysfunction in AML patients with early relapse post–allo-HSCT
por: Wang, Dongyao, et al.
Publicado: (2022)

Transcriptomic characteristics and impaired immune function of patients who retest positive for SARS-CoV-2 RNA
por: Wang, Dongyao, et al.
Publicado: (2021)

Recent Advances and Challenges in Uveal Melanoma Immunotherapy
por: Fu, Yihang, et al.
Publicado: (2022)

Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status
por: Zhou, Yonggang, et al.
Publicado: (2021)

Cytokine-Based Generation of CD49a(+)Eomes(−/+) Natural Killer Cell Subsets
por: Ni, Xiang, et al.
Publicado: (2018)

Current insights into the hepatic microenvironment and advances in immunotherapy for hepatocellular carcinoma
por: Zhao, Ming, et al.
Publicado: (2023)

Advances in hepatitis B therapeutics
por: Soriano, Vicente, et al.
Publicado: (2020)

IGF-1 promotes the development and cytotoxic activity of human NK cells
por: Ni, Fang, et al.
Publicado: (2013)

CD4(+) T Cells in Chronic Hepatitis B and T Cell-Directed Immunotherapy
por: Buschow, Sonja I., et al.
Publicado: (2021)

Influenza Vaccine Induces Intracellular Immune Memory of Human NK Cells
por: Dou, Yaling, et al.
Publicado: (2015)

A long noncoding RNA positively regulates CD56 in human natural killer cells
por: Zhang, Ruya, et al.
Publicado: (2016)

Recent Advances in Hepatitis B Treatment
por: Prifti, Georgia-Myrto, et al.
Publicado: (2021)

Advances in treatment and prevention of hepatitis B
por: Shah, Niraj James, et al.
Publicado: (2021)

Advancing to the era of cancer immunotherapy
por: Wang, Yun, et al.
Publicado: (2021)

Current status and advances of immunotherapy in nasopharyngeal carcinoma
por: Xu, Jian-Ying, et al.
Publicado: (2022)

Advancements in Cancer Immunotherapies
por: Roy, Ruchi, et al.
Publicado: (2022)

Immunotherapy of hepatocellular carcinoma with infection of hepatitis B or C virus
por: Bonilla, Cecilia Monge, et al.
Publicado: (2020)

Recent advances in cancer immunotherapy
por: Sun, Qiang, et al.
Publicado: (2021)

Recent advances in managing hepatitis B
por: McMahon, Brian J
Publicado: (2010)

The Advancement of Nanomaterials for the Detection of Hepatitis B Virus and Hepatitis C Virus
por: Shi, Wanting, et al.
Publicado: (2023)

Technical advances in NK cell-based cellular immunotherapy
por: Fang, Fang, et al.
Publicado: (2019)

Advances in Immunotherapy for Adult Glioblastoma
por: Chokshi, Chirayu R., et al.
Publicado: (2021)

Advances in Immunotherapy for Hepatocellular Carcinoma
por: Hagiwara, Satoru, et al.
Publicado: (2023)

Advances in Engineering Cells for Cancer Immunotherapy
por: Xu, Xiao, et al.
Publicado: (2019)

Advances in Immunotherapy of Malignant Pleural Mesothelioma
por: Liao, Dongying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kkjfrdlgq19ocm95pril4oov53